The 11th World Congress on Heart and Cardiovascular Diseases is a premier event dedicated to advancing the understanding, treatment, and prevention of cardiovascular disease. Scheduled for February 27-28 in Paris, this conference brings together global leaders in cardiology, healthcare professionals, researchers, and industry innovators to tackle the world’s most pressing cardiovascular health challenges. With cardiovascular disease continuing as the leading cause of death worldwide, this conference is an essential platform for exploring emerging trends, breakthrough research, and innovative solutions aimed at reducing the burden of heart disease. Under the theme, "The Heart of the Matter: Emerging Trends in Cardiology," the event covers a diverse range of topics—from advanced diagnostics and AI-powered tools to novel treatments, interventional techniques, and preventative strategies. The conference offers a unique combination of keynote presentations, panel discussions, and hands-on workshops designed to enhance clinical knowledge, inspire collaboration, and fuel innovation. Participants will have the chance to engage directly with renowned experts, gain insights into the latest clinical practices, and connect with peers from around the world who share a commitment to improving cardiovascular health outcomes. Join us in Paris for this impactful event and be part of a global movement dedicated to advancing heart health and transforming lives.
Learn from Global Experts | Stay Ahead of Emerging Trends | Expand Your Network | Participate in Interactive Workshops | Shape the Future of Cardiovascular Care | Experience Paris
Cardiologists and Cardiac Surgeons | Researchers and Academics | Healthcare Providers and Allied Health Professionals | Medical Technologists and Innovators | Pharmaceutical and Biotech Professionals | Public Health Experts and Policy Makers | Medical Students and Early-Career Professionals | Primary Care Physicians and General Practitioners | Health Administrators and Healthcare Executives
Scientiic Sessions:
1. Interventional Cardiology and Structural Heart Disease
This session explores state-of-the-art catheter-based techniques and minimally invasive interventions for structural heart disease, including advancements in transcatheter aortic valve replacement (TAVR) and mitral valve repair. Experts will discuss how these innovations reduce recovery time, improve patient outcomes, and make complex procedures accessible to high-risk patients. The session will cover clinical case studies, patient selection, and the latest devices that are reshaping structural heart care.
2. Advanced Cardiac Imaging and Diagnostics
With breakthroughs in imaging technologies, this session examines the role of advanced modalities like cardiac MRI, CT angiography, and 3D echocardiography in improving diagnosis accuracy. Discussions will focus on AI-driven imaging analysis, which enhances early detection and enables personalized treatment planning. Attendees will learn about practical applications, emerging technologies, and how these tools help clinicians make faster, more informed decisions in complex cases.
3. Heart Failure: Management and Therapies
This session addresses the comprehensive management of heart failure, including the latest drugs, medical devices, and lifestyle interventions designed to improve patient quality of life. Topics will include innovative treatments such as SGLT2 inhibitors, ventricular assist devices (VADs), and stem cell therapy. The session will also explore new guidelines and strategies for reducing hospitalizations and mortality rates in heart failure patients through an individualized approach.
4. Arrhythmias and Electrophysiology
Focusing on the causes, detection, and treatment of arrhythmias, this session highlights advancements in electrophysiology, such as catheter ablation, pacemakers, and defibrillators. Experts will delve into management strategies for atrial fibrillation and ventricular tachycardia, as well as new insights into genetic predispositions for arrhythmias. Attendees will gain valuable knowledge on both the technical and therapeutic aspects of treating complex arrhythmic conditions.
5. Hypertension and Vascular Health
This session provides an in-depth look at hypertension management and vascular health, covering everything from pharmacologic treatments to lifestyle interventions. It includes discussions on new antihypertensive drugs, strategies for preventing vascular complications, and the importance of controlling blood pressure in patients at risk of cardiovascular events. Participants will also explore the connection between vascular health and overall heart function, highlighting ways to reduce peripheral artery disease and stroke risks.
6. Cardio-Oncology: Protecting the Heart in Cancer Patients
As cancer treatments often pose cardiovascular risks, this session covers the growing field of cardio-oncology. Experts will discuss screening methods, risk stratification, and protective strategies for patients undergoing chemotherapy or radiation. Topics include heart damage prevention, monitoring guidelines, and treatment options tailored for cancer patients. Attendees will learn how to balance effective cancer treatment with maintaining heart health, a critical focus in cardio-oncology today.
7. Pediatric Cardiology and Congenital Heart Disease
This session is dedicated to the unique cardiovascular needs of pediatric patients and individuals with congenital heart disease (CHD). It will cover the latest surgical techniques, minimally invasive procedures, and long-term management strategies for congenital defects. Experts will also discuss the challenges of transitioning young patients to adult care and innovations that improve outcomes for infants, children, and adolescents living with CHD.
8. Genomics and Precision Medicine in Cardiology
Personalized medicine is revolutionizing cardiology, and this session focuses on how genomics is transforming the diagnosis and treatment of heart disease. Topics include genetic testing for cardiovascular risk, pharmacogenomics, and tailored interventions based on a patient’s genetic profile. Participants will learn about emerging tools for identifying inherited heart conditions and gain insights into how precision medicine can lead to more effective, customized care for each patient.
9. Preventive Cardiology and Lifestyle Medicine
Emphasizing prevention, this session explores lifestyle modifications, community-based interventions, and public health strategies to reduce cardiovascular disease. Topics include diet, exercise, stress management, and smoking cessation as foundational elements in preventing heart disease. Experts will discuss evidence-based methods for risk reduction, population health programs, and the role of lifestyle medicine in managing chronic conditions and preventing heart attacks and strokes.
10. Digital Health and Telecardiology
Digital health is transforming cardiology, and this session focuses on the latest tools and technologies in telecardiology, wearable devices, and mobile health applications. Attendees will learn how remote monitoring, telemedicine, and data analytics enable more proactive, continuous care for heart patients. The session will also discuss challenges such as data security, patient compliance, and integration of digital tools into traditional clinical workflows.
Market Analysis Report
The global interventional cardiology devices market size was valued at USD 13.78 billion in 2023 and it is predicted to surpass around USD 27.72 billion by 2033 with a CAGR of 7.24% from 2024 to 2033.
Key Pointers
The interventional cardiology devices market is a rapidly evolving sector in healthcare, focused on combating cardiovascular diseases through advanced medical devices and procedures. With conditions like coronary artery disease and heart attacks remaining top causes of morbidity and mortality worldwide, interventional cardiology devices are essential for diagnosing, treating, and managing these critical health issues.
The interventional cardiology devices market is experiencing steady growth driven by several key factors. The rising global prevalence of cardiovascular diseases increases the demand for advanced devices and procedures. Continuous technological advancements have led to more innovative and effective devices, further fueling market expansion. Additionally, the aging population, which is more prone to heart-related conditions, significantly contributes to the demand for interventional cardiology solutions. A growing preference for minimally invasive procedures, favored by patients and healthcare professionals alike, supports higher adoption rates. Enhanced awareness of early diagnosis and prompt treatment, combined with improved healthcare infrastructure, also propels market growth. Together, these elements are advancing the interventional cardiology devices market, enhancing patient outcomes and transforming cardiovascular care.
Report Coverage | Details |
Revenue Share of North America in 2023 | 38% |
CAGR of Asia Pacific from 2024 to 2033 | 7.96% |
Revenue Forecast by 2033 | USD 27.72 billion |
Growth Rate from 2024 to 2033 | CAGR of 7.24% |
Base Year | 2023 |
Forecast Period | 2024 to 2033 |
Market Analysis (Terms Used) | Value (US$ Million/Billion) or (Volume/Units) |
Visa Trip Advisor
Planning a trip to London, UK? Join our meeting!
Need help with your visa?
To assist participants with their visa applications, we provide the following support documents:
Important Points:
To arrange for a Visa Letter, please contact our Program Manager, Mr. Ricky Roy at heartconference@conferencesinternational.org..
To request your Visa Letter, please provide:
Payment Options:
Need help with registration?
Contact Mr. Ricky Roy at heartconference@conferencesinternational.org. The HEART CONGRESS 2025 team will provide you with an invoice for the requested amount to facilitate a bank transfer
Advantages of Participation
Participation Options
Heart Congress 2025 offers various ways to engage, categorized into Academic, Student, and Business sections:
Benefits of Attending the Conference
Benefits for Speakers
Benefits for Delegates
Benefits for Sponsors
Benefits for Collaborators
Sponsors:
Elite Sponsor Benefits
Gold Sponsor Benefits
Silver Sponsor Benefits
Exhibition Sponsorship Benefits: